24 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement. To the knowledge of the Company, no executive officer
8-K
EX-10.1
6zp5xgu62twdus5dqu
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-1.1
nutoscar3l maln
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
wpi9gqz eeplw7lpsm1b
5 Oct 20
Prospectus supplement with pricing info
4:16pm
424B3
ivffeulzu0kaq3iu31yg
9 Nov 18
Prospectus supplement
5:04pm